Positron emission tomography (PET) is a noninvasive imaging technique that provides a
functional or metabolic assessment of normal tissue or disease conditions. Fluorine 18 …

OBJECTIVE. CT remains the imaging modality of choice in the diagnosis of colorectal
cancer (CRC) and anal cancer. However, advances in imaging have expanded the role of …

Purpose The purpose was to investigate the diagnostic performance of different
combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT for …

Purpose To evaluate the added clinical value of pretreatment 18 F-FDG PET/CT compared
with conventional contrast-enhanced multidetector-row CT (CECT) alone for staging of …

Positron Emission Tomography (PET) is a diagnostic imaging procedure used regularly to
acquire essential clinical information. The PET-CT hybrid, which consists of two scanning …

Fluorodeoxyglucose (FDG)-PET/computed tomography (CT) imaging enables clinicians to
assess cancer biology and perform staging, restaging, and treatment monitoring of cancers …

AIM: To assess the clinical impact of 2-[18F]-fluoro-2-deoxy-d-glucose (FDG) positron-
emission tomography–computed tomography (PET-CT) in patients with potentially …

Positron-emission tomography (PET), a diagnostic imaging technique using an agent
labeled with a positron-emitting radionuclide, may facilitate improved diagnosis and …

Objective To determine whether contrast-enhanced PET/CT is more accurate than either
non-enhanced PET/CT or enhanced CT alone for nodal staging of uterine cancer. Methods …

Purpose To evaluate low-dose non-enhanced CT (ldCT) and full-dose contrast-enhanced
CT (ceCT) in integrated 18 F-fluorodeoxyglucose (FDG) PET/CT studies for restaging of …